Come up with a name for your new list and we'll add to it:
ONL Therapeutics raised a round of funding on March 21, 2017. Investors include
National Eye Institute.
ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors. Existing therapies have significant limitations and none address the initial ne…